The ibogaine microdose protocol is possible using a psychoactive indole alkaloid sourced from the West African herbaceous shrub Tabernanthe iboga, famed for its “anti-addictive” properties that work wonders in treating drug addiction without searing side effects.
What exactly do you mean by Microdosing?
Microdosing is the process of ingesting minute titrated doses of a drug, just enough to induce psychoactive effects in a clinically controlled environment where the subject can be monitored and medically treated.
In the pharmaceutical industry, microdosing typically involves 1 percent of the regular dose with carefully calibrated potency, which is then used to assess the efficacy of new drugs.
In microdosing ibogaine, 5 to 10 percent of the drug is administered to spark and study the drug’s psychoactive effect, and the dosage is repeated at regular intervals over a longer gestation to treat the patients’ existing mental health issues.
Potential Health Benefits of Iboga Microdosing
Microdosing as a psychoanalytic tool is steadily gaining recognition in the medical fraternity. Big Pharma’s continuing usage of microdosing as standard laboratory protocol has only augmented microdosing’s credibility.
The potential benefits of microdosing iboga are the following:
- Enhanced cognitive response with improved physical health indices.
- Improved energy levels with corresponding activity boost
- Better emotional stability and less disruptive mood swings
- Reduced anxiety with improved stress management
- Rediscovering enhanced self-caring pathways
- Enhanced sensory experiences leading to a better appreciation of life and living.
- Raised cardiovascular endurance leading to better physical fitness.
- Reduced day napping and better-quality night sleep schedules that are more profound, more restful.
- Mitigates the deleterious effects of drug addiction related trauma.
- Lastly, a marked improvement in treating drug addiction and elimination of substance abuse proclivity
A 2020 survey of 1102 psychedelically microdosed volunteers revealed:
- 21 percent reported depression climbdown after microdosing.
- 7 percent claimed improved anxiety control.
- 9 percent reported marked improvement in mental health problems.
- 2 percent used microdosing to combat and heal chronic substance abuse.
The 2020 survey findings prove that depression, anxiety, addiction and psychosomatic distress can be treated using microdosing with psychedelic drugs under medical supervision.
Pitfalls Ibogaine Microdosing and Risks of Substance Abuse
In clinical pathology, the universally accepted definition of substance abuse is repeated use of prescription drugs, illegal opiates, over-the-counter prescriptions, or rapidly rising alcohol dependency that exceeds the intended purpose and leads to psychosomatic distress symptoms that indicate poor health.
Ibogaine treatment for depression cannot be cited as an example of substance abuse or labeled a deviant medical protocol because the medically supervised procedure does not involve taking excessive quantities of ibogaine for unintended purposes.
Notwithstanding Iboga’s positive reviews, psychedelics are still categorized as illegal drugs in the United States. The increasing body of clinical evidence of iboga microdose benefits opens avenues for broader, medically coordinated programs alleviating mental health issues.
Clinically based evidence shows that ibogaine microdosing does not lead to increased addiction or deleterious side effects. But patients admitted for treatment exhibit the following symptoms underlying mental health problems:
- General proclivity for aggressive or violent behavior
- Significant deterioration in the way people see and feel about their bodies and the way they look. The negative body image is a persistent problem.
- Increased hyperactivity is seen outwardly in constant motion, excessive fidgeting, and frequent craving for tactile sensory activity. The repetitive activity tires out the individual.
- Major depressive disorder manifests as one’s inability to feel pleasure (Anhedonia), consumed by dark, dull, depressing moods.
- Depression-fueled hyperactivity and mood swings create repetitive thought streams that lead to insomnia.
- Worsening gastrointestinal symptoms lead to loss of appetite and unusual weight loss. Irritable bowel syndrome is a prime example of anxiety and stress-induced gut problems.
- Excessive stimulation of serotonin receptors may lead to tremors or shaking of limbs. Nerve damage makes muscles twitch under the skin. Hypothermia sets in when the body loses its natural thermostatic ability.
Notwithstanding the symptoms of chronic (pre-treatment) drug addiction, a considerable body of clinical data exists to prove that iboga microdosing has no links to compulsive drug abuse and is, in fact, a healing agent in tackling many mental health disorders.
Conclusion
Following the discovery of LSD in 1943 and its categorization as a drug in the psychedelic class, advances in medical science unraveled a vital phenomenon – that of microdosing – meaning the administration of minute doses of such a drug could potentially deliver health benefits.
Microdosing Ibogaine in small doses over an extended period has gathered enough clinical evidence to prove that the practice can improve mood, enhance cognition, treat several mental health disorders simultaneously and heal drug addiction.
The most effective Ibogaine medication delivered in controlled clinical conditions significantly mitigates potential risks and promotes safer health benefits without withdrawal effects.
Hi, I’m the Founder and Developer of Paramedics World, a blog truly devoted to Paramedics. I am a Medical Lab Tech, a Web Developer and Bibliophiliac. My greatest hobby is to teach and motivate other peoples to do whatever they wanna do in life.